Elite Pharmaceuticals (ELTP) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 41.7%
EBITDA Margin: 24.1%
Op. Margin: 23.3%
Net Margin: 18.3%

Op. margin of 23.3% is down 30.7% YoY — costs are rising relative to revenue. Net margin at 18.3% and gross margin of 41.7% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit